Neurogene
NGNE
$24.20
Share price
-1.23%
Change (1 day)
-64.36%
Change (1 year)
Neurogene (NGNE) - Cash on Hand
Cash on Hand as of September 2024 : A$0.22 Billion
According to Neurogene's latest financial reports the company has A$0.22 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Neurogene - Cash on Hand chart (from 2023 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | A$0.28 B | 140.09% |
| 2022-12-31 | A$0.12 B | 23.87% |
| 2021-12-31 | A$97.3 M |